Acasti Pharma Management
Management criteria checks 2/4
Acasti Pharma's CEO is Prashant Kohli, appointed in Apr 2023, has a tenure of 1.08 years. total yearly compensation is $415.51K, comprised of 68.1% salary and 31.9% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $60.87K. The average tenure of the management team and the board of directors is 1 years and 0.9 years respectively.
Key information
Prashant Kohli
Chief executive officer
US$415.5k
Total compensation
| CEO salary percentage | 68.1% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.2% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
We're Keeping An Eye On Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
Apr 20
Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?
Nov 14We're Not Very Worried About Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
May 10Acasti Pharma GAAP EPS of -$0.10
Aug 11Acasti inks deal for Grace Therapeutics, shares surge
May 07Acasti Pharma issues clarification on trading activity
Dec 23Acasti Pharma EPS in-line
Nov 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$39m |
| Sep 30 2023 | n/a | n/a | -US$40m |
| Jun 30 2023 | n/a | n/a | -US$42m |
| Mar 31 2023 | US$416k | US$283k | -US$42m |
| Dec 31 2022 | n/a | n/a | -US$17m |
| Sep 30 2022 | n/a | n/a | -US$17m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | US$655k | US$141k | -US$10m |
Compensation vs Market: Prashant's total compensation ($USD415.51K) is below average for companies of similar size in the US market ($USD674.46K).
Compensation vs Earnings: Prashant's compensation has been consistent with company performance over the past year.
CEO
Prashant Kohli (51 yo)
1.1yrs
Tenure
US$415,513
Compensation
Mr. Prashant Kohli was Vice President of Commercial Operations at Grace Therapeutics, Inc. He served as Chief Commercial Officer at Acasti Pharma Inc. since 2022 until April 04, 2023, and serves as its Chi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | US$415.51k | 0.23% $ 60.9k | |
| Principal Financial & Accounting Officer | less than a year | no data | no data | |
| Member of Scientific Advisory Board & Chief Medical Officer | less than a year | no data | no data | |
| VP of Program Management | less than a year | no data | 0.12% $ 31.7k | |
| VP of Clinical Operations | less than a year | no data | no data |
1.0yrs
Average Tenure
51yo
Average Age
Experienced Management: ACST's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$415.51k | 0.23% $ 60.9k | |
| Member of Scientific Advisory Board & Chief Medical Officer | 2yrs | no data | no data | |
| Independent Director | less than a year | no data | 0.40% $ 108.0k | |
| Independent Director | less than a year | no data | no data | |
| Independent Chairman | 2.8yrs | US$96.19k | 12.64% $ 3.4m | |
| Director | less than a year | US$406.23k | 3.94% $ 1.1m | |
| Member of Scientific Advisory Board | 2yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.3yrs | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
0.9yrs
Average Tenure
55yo
Average Age
Experienced Board: ACST's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.